Overview

Angiotensin II for Septic Shock Treatment

Status:
Suspended
Trial end date:
2019-08-15
Target enrollment:
Participant gender:
Summary
This study aims to investigate the effect of angiotensin II on microcirculation and peripheral perfusion in patients with septic shock.
Phase:
Phase 3
Details
Lead Sponsor:
Cairo University
Treatments:
Angiotensin II
Angiotensinogen
Giapreza
Norepinephrine